Stock Market Reviews

COR (Cencora, Inc.) News

Get the latest news, insights, and market updates on COR (Cencora, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• 2 Large-Cap Stocks Worth Your Attention and 1 We Question
  Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
  Jan 2, 2026 - $COR
• Reasons to Add Cooper Companies Stock to Your Portfolio Now
  COO's revenues are showing strong growth as MyDay and MiSight drive momentum, while restructuring savings and buybacks bolster long-term upside despite near-term risks.
  Dec 30, 2025 - $COR
• Here's Why You Should Retain Glaukos Stock in Your Portfolio Now
  GKOS appears well-positioned for long-term growth as iDose TR adoption accelerates and Epioxa secures FDA approval, although reimbursement and execution risks remain.
  Dec 29, 2025 - $COR
• Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus
  Castle Biosciences surged 77.9% after a Zacks upgrade, highlighting how the firm's stock picks outpaced the broader market in recent months.
  Dec 29, 2025 - $COR
• Reasons to Retain Baxter International Stock in Your Portfolio Now
  BAX is reshaping its portfolio following the divestiture of Kidney Care, focusing on surgical strength, deleveraging and tighter execution to rebuild momentum.
  Dec 26, 2025 - $COR
• Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks
  As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at health insurance providers stocks, starting with Cencora (NYSE:COR).
  Dec 25, 2025 - $COR
• These 3 Medical Stocks Have Wall Street's Bullish Vote for 2026
  COR, ADUS and SEM earn bullish analyst support for 2026 as AI adoption, home care demand and facility expansion fuel medical sector growth.
  Dec 24, 2025 - $COR
• Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
  Merit Medical shows resilience despite 2025 share pressure, supported by cardiovascular growth, margin expansion and WRAPSODY CIE momentum.
  Dec 23, 2025 - $COR
• Zacks.com featured highlights include NVIDIA, Ralph Lauren, Expedia and Cencora
  NVIDIA leads a group of stocks near 52-week highs, as Zacks highlights momentum-driven upside potential alongside Ralph Lauren, Expedia and Cencora.
  Dec 23, 2025 - $COR
• 2 Large-Cap Stocks Worth Investigating and 1 We Find Risky
  Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
  Dec 22, 2025 - $COR